Your IP: 3.235.45.196 United States Near: United States

Lookup IP Information

Previous 1 2 3 4 5 6 7 8 

Below is the list of all allocated IP address in 110.157.0.0 - 110.157.255.255 network range, sorted by latency.

Detumomab ? Monoclonal antibody Type Whole antibody Source Mouse Target B-lymphoma cell Identifiers CAS number 145832-33-3 ATC code None Chemical data Formula  ? Therapeutic considerations Pregnancy cat.  ? Legal status  ?  Y(what is this?)  (verify) Detumomab is a mouse monoclonal antibody[1] developed for the treatment of cancer.[citation needed] References ^ WHO Drug Information v · d · eMonoclonal antibodies for tumors Tumor ("-t(u[m])-") Human ("-tumu-") Adecatumumab • Belimumab • Cixutumumab • Conatumumab • Figitumumab • Glembatumumab vedotin • Iratumumab • Lexatumumab • Lucatumumab • Mapatumumab • Necitumumab • Ofatumumab • Olaratumab • Panitumumab • Pritumumab • Robatumumab • Votumumab • Zalutumumab Mouse ("-tumo-") Altumomab pentetate • Anatumomab mafenatox • Arcitumomab • Bectumomab • Blinatumomab • CC49 • Detumomab • Ibritumomab tiuxetan • Minretumomab • Mitumomab • Naptumomab estafenatox • Nofetumomab merpentan • Pemtumomab • Pintumomab • Satumomab pendetide • Taplitumomab paptox • Tenatumomab • Tositumomab • 3F8 "-govo-" (ovarian tumor): Abagovomab • Igovomab • Oregovomab "-pro-" (prostate tumor): Capromab pendetide "-colo-" (colonic tumor): Edrecolomab • Nacolomab tafenatox Chimeric ("-tuxi-") Bavituximab • Brentuximab vedotin • Cetuximab • Siltuximab • Rituximab "-mexi-" (melanoma): Ecromeximab Humanized ("-tuzu-") Afutuzumab • Alemtuzumab • Bevacizumab • Bivatuzumab mertansine • Cantuzumab mertansine • Citatuzumab bogatox • Dacetuzumab • Elotuzumab† • Etaracizumab • Farletuzumab • Gemtuzumab ozogamicin • Inotuzumab ozogamicin • Labetuzumab • Lintuzumab • Matuzumab§ • Milatuzumab • Nimotuzumab • Oportuzumab monatox • Pertuzumab • Sibrotuzumab • Tacatuzumab tetraxetan • Tigatuzumab • Trastuzumab • Tucotuzumab celmoleukin • Veltuzumab Rat/mouse hybrid ("-tumaxo-") Catumaxomab • Ertumaxomab #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.v · d · e